| Patent application number | Description | Published |
|---|
| 20080200504 | Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula (I) wherein R | 08-21-2008 |
| 20080214605 | Alkyl Sulfoxide Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I | 09-04-2008 |
| 20080234269 | N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands - Compounds of Formula I | 09-25-2008 |
| 20080280949 | Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators - Compounds of Formula I wherein R | 11-13-2008 |
| 20080287492 | Alkylpyridyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula I | 11-20-2008 |
| 20080306110 | Alkylnitrile Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I | 12-11-2008 |
| 20090062282 | Substituted Amino-Pyrimidones and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia. | 03-05-2009 |
| 20090221579 | Substituted Amino-Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia. | 09-03-2009 |
